These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

997 related items for PubMed ID: 14581362

  • 1. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T, Katayama Y, Yoshino A, Komine C, Yokoyama T.
    Clin Cancer Res; 2003 Oct 15; 9(13):4884-90. PubMed ID: 14581362
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
    Endo M, Kobayashi C, Setsu N, Takahashi Y, Kohashi K, Yamamoto H, Tamiya S, Matsuda S, Iwamoto Y, Tsuneyoshi M, Oda Y.
    Clin Cancer Res; 2011 Jun 01; 17(11):3771-82. PubMed ID: 21262917
    [Abstract] [Full Text] [Related]

  • 3. Aberrant hypermethylation of p14ARF and O6-methylguanine-DNA methyltransferase genes in astrocytoma progression.
    Watanabe T, Katayama Y, Yoshino A, Yachi K, Ohta T, Ogino A, Komine C, Fukushima T.
    Brain Pathol; 2007 Jan 01; 17(1):5-10. PubMed ID: 17493032
    [Abstract] [Full Text] [Related]

  • 4. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status.
    Chaussade L, Eymin B, Brambilla E, Gazzeri S.
    Oncogene; 2001 Oct 04; 20(45):6587-96. PubMed ID: 11641784
    [Abstract] [Full Text] [Related]

  • 5. The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas.
    Ogino A, Yoshino A, Katayama Y, Watanabe T, Ota T, Komine C, Yokoyama T, Fukushima T.
    J Neuropathol Exp Neurol; 2005 May 04; 64(5):398-403. PubMed ID: 15892297
    [Abstract] [Full Text] [Related]

  • 6. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, Hauss J, Wittekind C.
    Oncogene; 2001 Oct 25; 20(48):7104-9. PubMed ID: 11704835
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P, Zaravinos A, Zioga M, Stratigos A, Baritaki S, Soufla G, Zoras O, Spandidos DA.
    Cancer Lett; 2008 Jun 08; 264(1):145-61. PubMed ID: 18331779
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The prognostic significance of p16(INK4a)/p14(ARF) locus deletion and MDM-2 protein expression in adult acute myelogenous leukemia.
    Faderl S, Kantarjian HM, Estey E, Manshouri T, Chan CY, Rahman Elsaied A, Kornblau SM, Cortes J, Thomas DA, Pierce S, Keating MJ, Estrov Z, Albitar M.
    Cancer; 2000 Nov 01; 89(9):1976-82. PubMed ID: 11064355
    [Abstract] [Full Text] [Related]

  • 11. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
    Chinnasri P, Pairojkul C, Jearanaikoon P, Sripa B, Bhudhisawasdi V, Tantimavanich S, Limpaiboon T.
    Hum Pathol; 2009 Jun 01; 40(6):817-26. PubMed ID: 19200577
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inactivation of the p14(ARF), p15(INK4B) and p16(INK4A) genes is a frequent event in human oral squamous cell carcinomas.
    Shintani S, Nakahara Y, Mihara M, Ueyama Y, Matsumura T.
    Oral Oncol; 2001 Sep 01; 37(6):498-504. PubMed ID: 11435176
    [Abstract] [Full Text] [Related]

  • 14. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis.
    Edamoto Y, Hara A, Biernat W, Terracciano L, Cathomas G, Riehle HM, Matsuda M, Fujii H, Scoazec JY, Ohgaki H.
    Int J Cancer; 2003 Sep 01; 106(3):334-41. PubMed ID: 12845670
    [Abstract] [Full Text] [Related]

  • 15. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P, Ichimura K, Collins VP, Reifenberger G.
    Am J Pathol; 2001 Aug 01; 159(2):661-9. PubMed ID: 11485924
    [Abstract] [Full Text] [Related]

  • 16. p16 is a major inactivation target in hepatocellular carcinoma.
    Jin M, Piao Z, Kim NG, Park C, Shin EC, Park JH, Jung HJ, Kim CG, Kim H.
    Cancer; 2000 Jul 01; 89(1):60-8. PubMed ID: 10897001
    [Abstract] [Full Text] [Related]

  • 17. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
    Smeds J, Berggren P, Ma X, Xu Z, Hemminki K, Kumar R.
    Carcinogenesis; 2002 Apr 01; 23(4):645-55. PubMed ID: 11960918
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P, Schmidt M, Hu X, Wolff L.
    Oncogene; 2003 Mar 20; 22(11):1600-10. PubMed ID: 12642863
    [Abstract] [Full Text] [Related]

  • 20. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma.
    Hutter G, Scheubner M, Zimmermann Y, Kalla J, Katzenberger T, Hübler K, Roth S, Hiddemann W, Ott G, Dreyling M.
    Genes Chromosomes Cancer; 2006 Feb 20; 45(2):203-10. PubMed ID: 16258956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.